Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78%

United States News News

Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78%
United States Latest News,United States Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 55%

Sanofi to cut US price of its most-prescribed insulin by 78%. MedTwitter diabetes

- Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co.

In addition to Lantus, Sanofi said it will cut by 70% the list price for its fast-acting insulin, Apidra. The company said it has a 40% share of the U.S. long-acting insulin market and a 4% share of the rapid-acting market. Most Americans with insurance do not regularly pay list price for insulin, but they may have an insurance co-pay based on the drug's list price or pay full price up to a certain amount of money spent.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co .
Read more »

Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi to cut US price of its most-prescribed insulin by 78%Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co .
Read more »

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%French drugmaker Sanofi SA said it would cut the price of some of its insulin products by as much as 78% in the U.S., joining other big diabetes drugmakers facing pressure over high costs.
Read more »

Sanofi Is Latest Drugmaker to Cut Insulin PricesSanofi Is Latest Drugmaker to Cut Insulin PricesSanofi is planning to cut the U.S. price of its most-prescribed insulin by 78% and cap monthly out-of-pocket costs at $35 for people who have private insurance. CNBC
Read more »

Sanofi is the latest insulin maker to announce price capSanofi is the latest insulin maker to announce price capSanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress to enact limits. MORE ⬇️
Read more »

Mission Valley River Crossings Closed After Storm Drenches San Diego; Flooded SR-78 Closed WestboundMission Valley River Crossings Closed After Storm Drenches San Diego; Flooded SR-78 Closed WestboundNon-stop overnight rain from the latest in a series of atmospheric river storms to reach San Diego County flooded streets, prompted dozens of crashes on rain-slicked roadways and downed trees across the county Wednesday.
Read more »



Render Time: 2025-02-21 09:11:36